Siwen Hu-Lieskovan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Prognostic Factors

Advanced Cancer

Ejection Fraction

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Lyndsay N Harris, Charles David Blanke, Harry P Erba, James M Ford, Robert C Gray, Michael L LeBlanc, Siwen Hu-Lieskovan, Mark R Litzow, Selina M Luger, Funda Meric-Bernstam, Peter J O'Dwyer, Megan K D Othus, Katerina Politi, Lois E Shepherd, Carmen J Allegra, Helen X Chen, Susan Percy Ivy, Larissa A Korde, Richard F Little, Lisa Meier McShane, Jeffrey A Moscow, David R Patton, Magdalena Thurin, Laura M Yee, James H Doroshow
The New NCI Precision Medicine Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Timothy Anthony Yap, Patricia M LoRusso, Deborah J Wong, Siwen Hu-Lieskovan, Kyriakos P Papadopoulos, Josefin-Beate Holz, Urszula Grabowska, Cristian Gradinaru, Kin-Mei Leung, Sylwia Marshall, Claire S Reader, Roslin Russell, Richard C A Sainson, Claire J Seal, Christopher J Shepherd, Fiona Germaschewski, Daniel R Gliddon, Omer Stern, Lesley Young, Neil Brewis, Louis Kayitalire, Michelle Morrow
A Phase 1 first-in-human study of FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1 in patients with advanced cancer and PD-L1 resistance. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)